Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids.


Journal

The Biochemical journal
ISSN: 1470-8728
Titre abrégé: Biochem J
Pays: England
ID NLM: 2984726R

Informations de publication

Date de publication:
15 01 2021
Historique:
received: 02 09 2020
revised: 20 11 2020
accepted: 27 11 2020
pubmed: 28 11 2020
medline: 17 4 2021
entrez: 27 11 2020
Statut: ppublish

Résumé

Glioblastoma (GBM) is the most aggressive brain cancer and its relapse after surgery, chemo and radiotherapy appears to be led by GBM stem cells (GSCs). Also, tumor networking and intercellular communication play a major role in driving GBM therapy-resistance. Tunneling Nanotubes (TNTs), thin membranous open-ended channels connecting distant cells, have been observed in several types of cancer, where they emerge to drive a more malignant phenotype. Here, we investigated whether GBM cells are capable to intercommunicate by TNTs. Two GBM stem-like cells (GSLCs) were obtained from the external and infiltrative zone of one GBM from one patient. We show, for the first time, that both GSLCs, grown in classical 2D culture and in 3D-tumor organoids, formed functional TNTs which allowed mitochondria transfer. In the organoid model, recapitulative of several tumor's features, we observed the formation of a network between cells constituted of both Tumor Microtubes (TMs), previously observed in vivo, and TNTs. In addition, the two GSLCs exhibited different responses to irradiation in terms of TNT induction and mitochondria transfer, although the correlation with the disease progression and therapy-resistance needs to be further addressed. Thus, TNT-based communication is active in different GSLCs derived from the external tumoral areas associated to GBM relapse, and we propose that they participate together with TMs in tumor networking.

Identifiants

pubmed: 33245115
pii: 227071
doi: 10.1042/BCJ20200710
pmc: PMC7800365
doi:

Substances chimiques

GAP-43 Protein 0

Banques de données

ClinicalTrials.gov
['NCT01872221']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-39

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Author(s).

Auteurs

Giulia Pinto (G)

Unité de Trafic Membranaire et Pathogenèse, Institut Pasteur, UMR3691 CNRS, 28 rue du Docteur Roux, F-75015 Paris, France.
Sorbonne Université, ED394 - Physiologie, Physiopathologie et Thérapeutique, F-75005 Paris, France.

Inés Saenz-de-Santa-Maria (I)

Unité de Trafic Membranaire et Pathogenèse, Institut Pasteur, UMR3691 CNRS, 28 rue du Docteur Roux, F-75015 Paris, France.

Patricia Chastagner (P)

Unité de Trafic Membranaire et Pathogenèse, Institut Pasteur, UMR3691 CNRS, 28 rue du Docteur Roux, F-75015 Paris, France.

Emeline Perthame (E)

Hub de Bioinformatique et Biostatistique - Département Biologie Computationnelle, Institut Pasteur, USR 3756 CNRS, F-75015 Paris, France.

Caroline Delmas (C)

Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1037, Institut Claudius Regaud, Université Toulouse III Paul Sabatier, Toulouse F-31000, France.

Christine Toulas (C)

Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1037, Institut Claudius Regaud, Université Toulouse III Paul Sabatier, Toulouse F-31000, France.

Elizabeth Moyal-Jonathan-Cohen (E)

Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1037, Institut Claudius Regaud, Université Toulouse III Paul Sabatier, Toulouse F-31000, France.

Christel Brou (C)

Unité de Trafic Membranaire et Pathogenèse, Institut Pasteur, UMR3691 CNRS, 28 rue du Docteur Roux, F-75015 Paris, France.

Chiara Zurzolo (C)

Unité de Trafic Membranaire et Pathogenèse, Institut Pasteur, UMR3691 CNRS, 28 rue du Docteur Roux, F-75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH